Investor Relations
Latest news
-
November 13, 2008
Theratechnologies: Last patient treated in the extension phase of the confirmatory study testing tesamorelin in HIV-associated lipodystrophy More...
-
November 6, 2008
Theratechnologies presents additional results from its tesamorelin Phase 3 studies at the 10th International workshop on adverse drug reactions and lipodystrophy in HIV More...
Events
-
From October 1 to 3, 2008
BioContact Québec, Québec City, Canada
Presentation by Yves Rosconi, President and Chief Executive Officer More...
-
From September 22 to 25, 2008
UBS Global Life Sciences Conference , New York City, USA
Presentation by Yves Rosconi, President and Chief Executive Officer More...